Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-080313
Filing Date
2025-06-02
Accepted
2025-06-02 16:30:18
Documents
1
Period of Report
2025-05-30

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5744
  Complete submission text file 0000950170-25-080313.txt   7266
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PMV PHARMACEUTICALS, INC. 8 CLARKE DRIVE, SUITE 3 CRANBURY NJ 08512
Business Address
Kung Winston (Reporting) CIK: 0001666963 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37348 | Film No.: 251015439